Document Detail

Rhodium-catalysed conjugate addition of arylboronic acids to enantiopure dehydroamino acid derivatives.
MedLine Citation:
PMID:  20835454     Owner:  NLM     Status:  In-Process    
The rhodium-catalysed conjugate addition of arylboronic acids to an enantiopure acceptor derived from (R)-S-methylcysteine proceeds under substrate control to provide a range of functionalised phenylalanine derivatives with excellent stereocontrol via a highly diastereoselective protonation.
Jonathan D Hargrave; Gerwyn Bish; Gabriele Kociok Köhn; Christopher G Frost
Related Documents :
11529774 - Synthesis of novel derivatives of 1,4,7-triazacyclononane.
16438034 - Synthesis of 9-[1-(substituted)-3-(phosphonomethoxy)propyl]adenine derivatives as possi...
18536164 - Synthesis and pharmacological properties of 1-[2-hydroxy-3-(4-o,m,p-halogenophenyl)- an...
16209584 - Chemically stabilized phenylboranylidene groups having a dimethoxytrityl group as a col...
7061494 - Discovery of an arachidonoyl coenzyme a synthetase in human platelets.
11590064 - Seeds for a better future: 'low phytate' grains help to overcome malnutrition and reduc...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-09-08
Journal Detail:
Title:  Organic & biomolecular chemistry     Volume:  8     ISSN:  1477-0539     ISO Abbreviation:  Org. Biomol. Chem.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-10-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101154995     Medline TA:  Org Biomol Chem     Country:  England    
Other Details:
Languages:  eng     Pagination:  5120-5     Citation Subset:  IM    
Department of Chemistry, University of Bath, Claverton Down, Bath, UKBA2 7AY.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Naturally occurring circular proteins: distribution, biosynthesis and evolution.
Next Document:  Novel dialkoxytriazine-type glycosyl donors for cellulase-catalysed lactosylation.